The Ministry of Social Affairs and Health (hereinafter ‘STM’) and Finnish institute for health and welfare (hereinafter ‘THL’ or ‘Customer’) request your tender for Meningococcal ACWY (MenACWY) Conjugate Vaccine belonging to the Vaccination Programme in the Finnish Defence Forces and for the medical risk groups within the National Vaccination Programme in Finland. The contract period is about two years during 2021-2023. The procurement contains two options to extend the contract for the periods 2023-2024 and 2024-2025. Estimated quantity for the contract period including option is 120 000 doses. Customer reserves the right to increase or decrease the ordered numbers of doses by up to 20 %. The contract will be awarded to one supplier based on a comparison of tenders. Tender that is economically the most advantageous will win the competition. Please note that all times given in the call for tender refer to local time in Finland. Tender Annexes: — Annex 1: Contract; — Annex 2: JYSE 2014 Supplies (Updated April 2017) (link).
Määräaika
Tarjousten vastaanottamisen määräaika oli 2021-01-29.
Hankinta julkaistiin 2020-12-22.
Toimittajat
Seuraavat toimittajat mainitaan hankintapäätöksissä tai muissa hankinta-asiakirjoissa:
hankintailmoitus (2020-12-22) Kohde Hankinnan laajuus
Otsikko: Rokotteet
Viitenumero: VN/1166/2020
Lyhyt kuvaus:
The Ministry of Social Affairs and Health (hereinafter ‘STM’) and Finnish institute for health and welfare (hereinafter ‘THL’ or ‘Customer’) request your tender for Meningococcal ACWY (MenACWY) Conjugate Vaccine belonging to the Vaccination Programme in the Finnish Defence Forces and for the medical risk groups within the National Vaccination Programme in Finland.
The contract period is about two years during 2021-2023. The procurement contains two options to extend the contract for the periods 2023-2024 and 2024-2025.
Estimated quantity for the contract period including option is 120 000 doses. Customer reserves the right to increase or decrease the ordered numbers of doses by up to 20 %.
The contract will be awarded to one supplier based on a comparison of tenders. Tender that is economically the most advantageous will win the competition.
Please note that all times given in the call for tender refer to local time in Finland.
Tender Annexes:
— Annex 1: Contract;
— Annex 2: JYSE 2014 Supplies (Updated April 2017) (link).
The Ministry of Social Affairs and Health (hereinafter ‘STM’) and Finnish institute for health and welfare (hereinafter ‘THL’ or ‘Customer’) request your tender for Meningococcal ACWY (MenACWY) Conjugate Vaccine belonging to the Vaccination Programme in the Finnish Defence Forces and for the medical risk groups within the National Vaccination Programme in Finland.
The contract period is about two years during 2021-2023. The procurement contains two options to extend the contract for the periods 2023-2024 and 2024-2025.
Estimated quantity for the contract period including option is 120 000 doses. Customer reserves the right to increase or decrease the ordered numbers of doses by up to 20 %.
The contract will be awarded to one supplier based on a comparison of tenders. Tender that is economically the most advantageous will win the competition.
Please note that all times given in the call for tender refer to local time in Finland.
Tender Annexes:
— Annex 1: Contract;
— Annex 2: JYSE 2014 Supplies (Updated April 2017) (link).
Ilmoituksen metatiedot
Alkukieli: englanti 🗣️
Asiakirjatyyppi: hankintailmoitus
Sopimuksen luonne: Tavarat
Asetus: Euroopan unioni ja WTO-maat
Yhteinen hankintanimikkeistö (CPV)
Koodi: Rokotteet📦 Suorituspaikka
NUTS-alue: Suomi/Finland
🏙️
Menettely
Menettelyn tyyppi: Avoin menettely
Tarjouksen tyyppi: Tarjous koskee kaikkia eriä
Myöntämisperusteet
Alin hinta
This procurement is detailed in the contract notice published on TED (Tenders Electronic Daily) online version and on the HILMA Public Procurement website as well as this call for tender and its Annexes.
Kohde Hankinnan laajuus
Lyhyt kuvaus:
The Ministry of Social Affairs and Health (hereinafter ‘STM’) and Finnish institute for health and welfare (hereinafter ‘THL’ or ‘Customer’) request your tender for Meningococcal ACWY (MenACWY) Conjugate Vaccine belonging to the Vaccination Programme in the Finnish Defence Forces and for the medical risk groups within the National Vaccination Programme in Finland.
The Ministry of Social Affairs and Health (hereinafter ‘STM’) and Finnish institute for health and welfare (hereinafter ‘THL’ or ‘Customer’) request your tender for Meningococcal ACWY (MenACWY) Conjugate Vaccine belonging to the Vaccination Programme in the Finnish Defence Forces and for the medical risk groups within the National Vaccination Programme in Finland.
The contract period is about two years during 2021-2023. The procurement contains two options to extend the contract for the periods 2023-2024 and 2024-2025.
Estimated quantity for the contract period including option is 120 000 doses. Customer reserves the right to increase or decrease the ordered numbers of doses by up to 20 %.
The contract will be awarded to one supplier based on a comparison of tenders. Tender that is economically the most advantageous will win the competition.
Please note that all times given in the call for tender refer to local time in Finland.
Tender Annexes:
— Annex 1: Contract;
— Annex 2: JYSE 2014 Supplies (Updated April 2017) (link).
The purpose of STM and the customer is to procure Meningococcal ACWY (MenACWY) conjugate vaccine required for the vaccination programme in the Finnish Defence forces and for the medical risk groups within the National Vaccination Programme in Finland. Tendered vaccine must be suitable for adults and children because both adults and children may belong to the Medical Risk Groups. The customer will implement the procurement on behalf of STM. The roles of STM and customer are described in more detail in section ‘Presentation of the contracting authority’.
The purpose of STM and the customer is to procure Meningococcal ACWY (MenACWY) conjugate vaccine required for the vaccination programme in the Finnish Defence forces and for the medical risk groups within the National Vaccination Programme in Finland. Tendered vaccine must be suitable for adults and children because both adults and children may belong to the Medical Risk Groups. The customer will implement the procurement on behalf of STM. The roles of STM and customer are described in more detail in section ‘Presentation of the contracting authority’.
The subject of procurement and the mandatory requirements relating to it are described in detail in this call for tender and its Annexes. The contract will be awarded to one supplier based on a comparison of tenders.
Contract Period
The contract's duration is about 2 years. Estimated quantity for the contract period is 60 000 doses. The customer reserves the right to increase or decrease the ordered numbers of doses by up to 20 %.
The contract period shall enter into force once the contract has been signed, and expire when all contractual duties have been performed. After the contract period, the customer reserves the right for the option described in section ‘Description of renewals’.
The contract period shall enter into force once the contract has been signed, and expire when all contractual duties have been performed. After the contract period, the customer reserves the right for the option described in section ‘Description of renewals’.
Tenders will be compared in the manner described in section ‘Grounds for decision’ of the call for tender.
Kesto: 24 kuukautta
Uudistusten kuvaus:
The procurement contains 2 option years (1 + 1) to extend the contract. Estimated quantity for each option period is 30 000 doses (+/- 20 %). The customer can extend the contract 1 year at a time.
Lisätietoja:
This procurement is detailed in the contract notice published on TED (Tenders Electronic Daily) online version and on the HILMA Public Procurement website as well as this call for tender and its Annexes.
Oikeudelliset, taloudelliset, rahoitukselliset ja tekniset tiedot Osallistumisehdot
Kelpoisuus harjoittaa ammattitoimintaa:
Please see sections other information of the call for tender and the European Single Procurement Document (ESPD).
Sopimuksen toteuttaminen
Sopimuksen täytäntöönpanoehdot:
Please see sections other information of the call for tender and the European Single Procurement Document (ESPD).
Menettely
Oikeusperusta: 32014L0024
Tarjousten vastaanottoaika: 12:00
Kielet, joilla tarjoukset tai osallistumishakemukset voidaan jättää: englanti 🗣️
Tarjouksen voimassaoloaika: 6 kuukautta
Tarjousten avauspäivä: 2021-01-29 📅
Tarjousten avausaika: 13:00
Paikka: The opening of the tenders is not a public event.
Viite Lisätietoja
Arvioitu aikataulu seuraavien ilmoitusten julkaisemiselle: The following procurement is estimated to happen in 2024.
Tenderers may ask clarification questions using the supplier portal. The questions must be in English and will be answered in English. To guarantee the equal treatment of tenderers, questions posed in any other way cannot be answered.
Please note that all times given in the call for tender refer to local time in Finland.
Please note that the online connection to the supplier portal is periodically slow and the download time will take time. Please fill out the tenders information in good time before the deadline expires.
Täydentävät tiedot Arvostelurunko
Nimi: The Market Court
Postiosoite: Radanrakentajantie 5
Postitoimipaikka: Helsinki
Postinumero: 00520
Maa: Suomi 🇫🇮
Puhelin: +358 295643300📞
Sähköposti: markkinaoikeus@oikeus.fi📧
Internetosoite: http://www.oikeus.fi/markkinaoikeus🌏
Lähde: OJS 2020/S 251-628504 (2020-12-22)
Ilmoitus tehdystä sopimuksesta (2021-09-17) Kohde Hankinnan laajuus
Viitenumero: THL/4981/8.00.02/2020
Lyhyt kuvaus:
The purpose of STM and the THL is to procure Meningococcal ACWY (MenACWY) Conjugate Vaccine required for the vaccination programme in the Finnish Defence forces and for the medical risk groups within the National Vaccination Programme in Finland. Tendered vaccine must be suitable for adults and children because both adults and children may belong to the medical risk groups.
The purpose of STM and the THL is to procure Meningococcal ACWY (MenACWY) Conjugate Vaccine required for the vaccination programme in the Finnish Defence forces and for the medical risk groups within the National Vaccination Programme in Finland. Tendered vaccine must be suitable for adults and children because both adults and children may belong to the medical risk groups.
The procurement contains two option years (1+1) to extend the contract. Estimated quantity for each option period is 30 000 doses (+/- 20%). The Customer can extend the contract one year at a time.
Sopimuksen tekeminen
Sopimuksen tekemispäivä: 2021-08-20 📅
Nimi: GlaxoSmithKline Oy
Kansallinen rekisterinumero: FI01083784
Postitoimipaikka: Espoo
Maa: Suomi 🇫🇮 Helsinki-Uusimaa
🏙️
Hankinnan kokonaisarvo: 2604000.0 EUR 💰
Tietoa tarjouskilpailuista
Saatujen tarjousten määrä: 2
Hankintaviranomainen Tunnistetiedot
Kansallinen rekisterinumero: 2229500-6
Yhteystiedot
Yhteyspiste: Finnish Institute for Healh and Welfare (THL)
Täydentävät tiedot Arvostelurunko
Nimi: Markkinaoikeus
Lähde: OJS 2021/S 184-478422 (2021-09-17)